Xiaoting Xu
Impact in
- Radiation top 10%
- Advanced Radiotherapy Techniques
-
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Lung Cancer Treatments and Mutations 2
- Oncology 6
- Co-authors
- Juying Zhou (8 shared papers)Wentao Hu (2 shared papers)Bruce G. Haffty (3 shared papers)Ning J. Yue (3 shared papers)Salma K. Jabbour (2 shared papers)Songbing Qin (6 shared papers)Zhiyuan Rui (1 shared paper)Weiyuan Yu (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)BMC Cancer (3 papers)Remote Sensing (2 papers)Dose-Response (2 papers)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Xiaoting Xu
35 papers receiving 307 citations
Peers
Comparison fields: 5 of 71
- Radiation 38
- Obstetrics and Gynecology 29
- Otorhinolaryngology 15
- Radiology, Nuclear Medicine and Imaging 44
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by Xiaoting Xu
This map shows the geographic impact of Xiaoting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Xu more than expected).
Fields of papers citing papers by Xiaoting Xu
This network shows the impact of papers produced by Xiaoting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Xu. The network helps show where Xiaoting Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 42 | |
| 2 | 2013 | 29 | |
| 3 | Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP. | 2017 | 27 |
| 4 | 2015 | 22 | |
| 5 | 2021 | 15 | |
| 6 | 2014 | 15 | |
| 7 | Expression and clinicopathological significance of Foxp3 and VISTA in cervical cancer. | 2021 | 14 |
| 8 | 2022 | 13 | |
| 9 | 2022 | 11 | |
| 10 | 2020 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2013 | 9 | |
| 13 | 2024 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2013 | 7 | |
| 17 | 2024 | 5 | |
| 18 | 2015 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2014 | 5 |
About Xiaoting Xu
Xiaoting Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Astronomy and Astrophysics, having authored 46 papers that have together received 307 indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (4 papers), Space Exploration and Technology (4 papers), Planetary Science and Exploration (4 papers), Astro and Planetary Science (3 papers), Head and Neck Cancer Studies (2 papers), Head and Neck Surgical Oncology (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Radiation (38 citations), Obstetrics and Gynecology (29 citations), Otorhinolaryngology (15 citations), Radiology, Nuclear Medicine and Imaging (44 citations) and Pulmonary and Respiratory Medicine (61 citations). Xiaoting Xu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Juying Zhou, Wentao Hu, Bruce G. Haffty, Ning J. Yue, Salma K. Jabbour, Songbing Qin, Zhiyuan Rui, Weiyuan Yu, Hongtao Xue and John Langenfeld. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, BMC Cancer, Remote Sensing, Dose-Response and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.